baber/WOPTO huggingface dataset:
Patent CA-2466981-A1 (CA)
Title: Motion simulator and method
Inventor: ROY PHILIPPE
IPC: G06F19/00
Filed: 2004-05-12
Abstract: A motion simulator for transmitting motion with respect to a floor as a function of motion signals associated to a video output. The motion simulator comprises a seating portion for accommodating a viewer viewing the video output. Actuators each have a first member and a second member interrelated by a degree of freedom. Each of the actuators has a degree of actuation connected to the seating portion for displacing the first member with respect to the second member along the degree of freedom as a function of actuation from the actuators in relation to the motion signals. The first member of each of the actuators is secured to the seating portion The second member of each of the actuators comprises a leg supporting the motion simulator on the floor, whereby the seating portion is movable as a function of actuation from the actuators.
Patent CA-2467203-A1 (CA)
Title: Dispositif de detection rapide du prion et kit d'essai
Inventor: HAJIZADEH KIAMARS
IPC: G01N33/68
Filed: 2002-11-14
Abstract: L'invention concerne des dispositifs d'essai, des systèmes ainsi que des kits d'essai conçus pour une détection rapide à spécificité élevée de la forme pathogène de la protéine prion responsable de maladies neurodégénératives affectant les humains et les animaux, telle que l'encéphalopathie spongiforme transmissible chez les bovins, les ovins, et les chats. L'invention est également utile pour tester la nourriture pour animaux fabriquée à partir de restes d'animaux. Les résultats sont disponibles en 0,5 à 20 minutes environ et de préférence en 5 à 10 minutes environ après que l'échantillon a été introduit dans le dispositif et le système. Lesdits dispositifs, systèmes et kits d'essai emploient la protéinase k pour supprimer la protéine prion non infectieuse de l'échantillon biologique, de sorte que ledit échantillon peut être analysé par immunochromatographie, afin de déterminer la présence et la concentration de la protéine prion pathogène. A cause de l'immobilisation d'une protéinase K sur un support solide pour supprimer in situ des composants parasites, selon l'invention, aucune extraction ultérieure du mélange à analyser souhaité n'est nécessaire. Tous les aspects de l'invention sont appropriés pour quantifier la quantité détectable minimale de la protéine prion pathogène dans un échantillon biologique. De plus, l'utilisation de la présente invention est appropriée pour ce domaine grâce à la simplicité de préparation dudit échantillon.
Patent CA-2470630-A1 (CA)
Title: Determining an operational limit of a power transmission line
Inventor: ZIMA MAREK
IPC: H02H6/00
Filed: 2002-12-11
Abstract: In a method, computer program and system for determining an operational limi t of a power transmission line, time-stamped current phasor information and voltage phasor information for a first end and a second end of the line are determined, an ohmic resistance of the line is computed from the phasor information, and an average line temperature is computed from the ohmic resistance. This allows to determine the average line temperature without dedicated temperature sensors. The average line temperature represents the actual average temperature and is largely independent of assumptions regardi ng line parameters.
Patent CA-2471743-A1 (CA)
Title: Deuterated substituted pyrazolylbenzylsulfonamides and medicaments comprising said compounds
Inventor: ALKEN RUDOLF-GIESBERT
IPC: C07D231/12
Filed: 2002-12-11
Abstract: The invention relates to deuterated substituted pyrazolylbenzylsulfonamides, medicaments comprising said compounds and the use of deuterated substituted pyrazolylbenzylsulfonamides for the symptomatic treatment of osteoarthritis and rheumatoid arthritis, reduction and treatment of neoplasia, in particular adenomatoidal colorectal polyps in the case of familial adenomatoidal polyposis, for the treatment of pain, in particular acute pain and dysmenorrhoea, in particular primary dysmenorrhoea. The invention further relates to pharmaceutical compositions, comprising deuterated substituted pyrazolylbenzylsulfonamides and the physiologically-acceptable salts thereof, in addition to pharmaceutically-acceptable adjuncts and/or additives, for the symptomatic treatment of osteoarthritis and rheumatoid arthritis, reduction and treatment of neoplasia, in particular adenomatoidal colorectal polyps in the case of familial adenomatoidal polyposis, for the treatment of pain, in particular acute pain and dysmenorrhoea, in particular primary dysmenorrhoea.
Patent CA-2473138-A1 (CA)
Inventor: VETTER JAMES W
IPC: A61B8/00
Filed: 1999-11-12
Abstract: A breast stabilization device for imaging and invasive medical procedures includes a shell configured to surround a superior portion of a breast when the breast rests on a substantially flat surface. The shell includes a first opening configured to allow at least a portion of a nipple-areolar complex of the breast to protrude therethrough. A first and second flange extend from the shell to secure the shell to the flat surface. A third flange may also be included to secure the shell to the patient's chest wall. The shell includes a substantially rigid outer member and a relatively softer inner member that is in contact with the patient's breast when the device is in use. The substantially rigid outer member includes a suction port and the relatively softer inner member includes a through holes in fluid communication with the suction port, to allow a patient's breast to be drawn toward the inner member when fluid is drawn from the suction port.  Imaging and interventional procedures may be carried out through the opening by making an incision in the superior portion of the peri-areolar border. Both surface and intra-tissue ultrasound may be utilized to localize the lesion and to provide real time imaging of the uncompressed and stabilized breast during the breast-stabilized biopsy or excisional procedure.
Patent CA-2473439-A1 (CA)
Title: Method for reversing the direction of rotation in two-stroke engines
Inventor: KUTZNER FRANK
IPC: F02D27/00
Filed: 2003-01-08
Abstract: The invention relates to a method for reversing the direction of rotation of a two-stroke engine by specifically adjusting a misfire during coasting. In order to determine the direction of rotation of the engine with only one sensor, cyclic variations of the angular velocity of the crank mechanism during coasting are determined by using an incremental transducer. By allocating the transducer segments information on the angle position of the crank mechanism can be obtained that is referred to in conjunction with a further position information obtained through a gap of the incremental transducer to determine the direction of rotation. A corresponding suitable sensor can be used in piston engines independently of the method for determining the angle position of the crank mechanism.
Patent CA-2473838-A1 (CA)
Inventor: JOHNSON PHILLIP LEE
IPC: A45F5/00
Filed: 2003-01-22
Abstract: The invention relates to a clip (300) for capturing at least one capture member (401) within a capture zone (311). A gate (320) blocks an opening (310a) of the capture zone to thereby capture the capture member(s). The clip may be attached to a person by way of an attachment member (350), such as an attachment hook. A personal device such as a mobile phone (10) may be secured to the clip via a capture member locatable within the capture zone.  Accordingly, the personal device is attachable to the person via the clip when worn by the person. The invention also relates to a clasp (500) that is capable of capturing a detention member (403) within a detention zone (530).
Patent CA-2477303-A1 (CA)
Inventor: DRONZEK PETER J JR
IPC: B42D5/02
Filed: 2003-02-14
Abstract: A card intermediate, as for identification, which includes a business from having one or more selectively-pattern-treated laminae diecut into it and adhesively secured to a film.
Patent CA-2480626-A1 (CA)
Inventor: TANEJA RAJNEESH
IPC: A61K38/09
Filed: 2003-01-31
Abstract: Provided herein is a method of enhancing endogenous gonadotropin and androgen production comprising administering a therapeutically effective amount of at least one GnRH agonist to a patient in need of such treatment.
Patent CA-2480820-A1 (CA)
Title: Gravity-fed in-line continuous processing system and method
Inventor: PARENT DONALD G
IPC: C23C14/56
Filed: 2003-03-27
Abstract: A gravity-few in-line continuous processing system (10) includes at least one processing chamber (12) disposed between a first load lock (14) and a second load lock (16). The second load lock is disposed lower than the first load lock. A first device (18) isolates the processing chamber from the first load lock. A second device (20) isolates the processing chamber from the second load lock. There is at least one track (22) through the processing chamber and the first and second load locks. The track is structured and arranged such that an article (24) slides thereon under the force of gravity. The apparatus also comprises an output tray (42), 4th device (20'), back of rotary barrel gate valves (60, 62, 64), 3rd devices (18'). The track is disposed at an angle (26) to horizontal (19).
Patent CA-2482740-A1 (CA)
Title: Endoscopic mucosal resection device and method of use
Inventor: NOBIS RUDOLPH
IPC: A61B18/00
Filed: 2004-09-28
Abstract: A medical apparatus and method useful for resecting tissue from the gastrointestinal tract are disclosed. The apparatus can include an RF tissue cutting device disposed inward of a side opening in the device. A tissue stop can be used to control the depth of tissue resected, and the tissue stop can include holes for communicating vacuum for drawing tissue into the side opening. The tissue stop can be electrically grounded with respect to the RF tissue cutting device, and the tissue stop can provide one pole of an RF electrical circuit.
Patent CA-2482819-A1 (CA)
Title: Communication terminal device and communication control method
Inventor: TANAKA TAKESHI
IPC: H04L69/14
Filed: 2003-04-18
Abstract: A communication terminal device capable of performing communication while supervising/controlling a plurality of different communication means. For example, in a communication terminal device (100) such as an OSI reference model hierarchically classified into a plurality of layers by different processing functions, by control of an operation controller (304) belonging to a predetermined layer, a processing unit (303) belonging to a predetermined layer can selectively use a plurality of processing units (301) belonging to lower layers. That is, for example, data distribution control means (309) controls data distribution means (307) by referencing which processing unit can be used among a plurality of processing units belonging to the lower layer, which processing unit has a high transmission efficiency of communication, with which processing unit communication can be performed with a desired partner, and the like. The data distribution means divides the transmission data supplied from an upper layer and distributes them to a plurality of processing units belonging to a lower layer.
Patent CA-2483931-A1 (CA)
Inventor: STORRS RICHARD WOOD
IPC: G01N33/49
Filed: 2003-04-24
Abstract: A platelet collection device comprising a centrifugal spin-separator contain er with a cavity having a longitudinal inner surface. A float in the cavity has a base, a platelet collection surface above the base, an outer surface. The float density is below the density of erythrocytes and above the density of plasma. The platelet collection surface has a position on the float which places it below the level of platelets when the float is suspended in separated blood. During centrifugation, a layer of platelets or buffy coat collects closely adjacent the platelet collection surface. Platelets are the n removed from the platelet collection surface. Movement of a float having a density greater than whole blood through the sedimenting erythrocytes releas es entrapped platelets, increasing the platelet yield.
Patent CA-2496477-A1 (CA)
Title: Synthesis of epothilones, intermediates thereto, analogues and uses thereof
Inventor: YOSHIMURA FUMIHIKO
IPC: C07D417/06
Filed: 2003-08-22
Abstract: The present invention provides compounds of formula (I): as described generally and in classes and subclasses herein. The present invention additionally provides pharmaceutical compositions comprising compounds of formula (I) and provides methods of treating cancer comprising administering a compound of formula (I).
Patent CA-2497350-A1 (CA)
Inventor: WAGNER ANDREAS H
IPC: C07H21/04
Filed: 2003-09-02
Abstract: L'invention concerne des oligonucléotides leurres ayant une séquence d'acide nucléique conforme à SEQ ID NO:1 à 36, ainsi que leur utilisation en tant que médicaments.
Patent CA-2497980-A1 (CA)
Inventor: KOZLOWSKI ANTONI
IPC: C08G63/48
Filed: 2003-09-09
Abstract: L'invention concerne un procédé permettant de préparer des dérivés de polymères hydrosolubles comportant un acide carboxylique terminal ou un ester de celui-ci. Le procédé décrit dans cette invention consiste à hydrolyser un orthoester d'un polymère hydrosoluble afin d'obtenir l'acide correspondant. En outre, cette invention concerne des polymères hydrosolubles comportant un acide carboxylique terminal ou un ester de celui-ci, des produits intermédiaires et des réactifs servant à la mise en oeuvre dudit procédé. Cette invention concerne également des gels, des préparations pharmaceutiques, des conjugués associés aux dérivés de polymères hydrosolubles décrits dans cette invention.
Patent CA-2499566-A1 (CA)
Title: Method and apparatus for loading a beneficial agent into an expandable medical device
Inventor: DIAZ STEPHEN HUNTER
IPC: A61L31/16
Filed: 2003-09-22
Abstract: The present invention relates to method and apparatus for dispensing a beneficial agent into an expandable medical device. The method includes the step of placing an expandable medical device on a mandrel, the medical device forming a cylindrical device having a plurality of openings and dispensing a beneficial agent into the plurality of openings.
Patent CA-2500755-A1 (CA)
Title: Catalyseur supporte dope de forme spherique et procede d'hydrotraitement et d'hydroconversion de fractions petrolieres contenant des metaux
Inventor: KRESSMANN STEPHANE
IPC: B01J23/883
Filed: 2005-03-21
Abstract: La présente invention concerne un catalyseur d'hydrotraitement et/ou d'hydroconversion de charges hydrocarbonées lourdes contenant des métaux, ledit catalyseur comprenant un support sous forme de billes à base d'alumine, au moins un métal catalytique ou un composé de métal catalytique du groupe VIB (colonne 6 de la nouvelle notatio n de la table périodique des éléments), éventuellement au moins un métal catalytique ou un composé de métal catalytique du groupe VIII (colonnes 8, 9, et 10 de la nouvelle notati on de la table périodique des éléments), dont la structure poreuse se compose d'une plurali té d'agglomérats juxtaposés, formés chacun d'une pluralité de plaquettes aciculaires, les plaquettes de chaque agglomérat étant orientées généralement radialement les unes vis-à-vis des autres et par rapport au centre de l'agglomérat. Le catalyseur renferme en outre au moins un élément dopant choisi dans le groupe constitué par le phosphore, le bore, le silicium (ou de la silice qui n'appartient pas à celle qui pourrait être contenue dans le support choisi) et les halogènes. L'invention concerne également l'utilisation dudit catalyseur pour la conversion de charges contenant des métaux.
Patent CA-2502180-A1 (CA)
Title: Pyrimido compounds having antiproliferative activity (ii)
Inventor: SCHEIBLICH STEFAN
IPC: A61P35/00
Filed: 2003-10-27
Abstract: Disclosed are novel pyrimido compounds of the formula (I) wherein R1 to R9 a re as defined in the specification, that are selective inhibitors of the Src family of tyrosine kinases. These compounds and their pharmaceutically acceptable salts are anti-proliferative agents useful in the treatment or control of solid tumors, in particular breast, colon, hepatic and pancreatic tumors. Also disclosed are pharmaceutical compositions containing these compounds and the use for treating cancer.
Patent CA-2502494-A1 (CA)
Title: Medical device sheath apparatus and method of making and using same
Inventor: MOYNIHAN SHAWN TIMOTHY
IPC: A61B1/00
Filed: 2003-10-15
Abstract: A medical device sheath apparatus (10) including: a fitting (20) being suitable for receiving the medical device (50) in a self sealing manner; a first sheath (32) for receiving the medical device (50) as it passes through the fitting (20); a second sheath (34) surrounding the first sheath (32); a dilator (104) defining a treatment area, coupled to at least the second sheath (34), and being suitable for dilating a body cavity and passing therapeutic or diagnostic energy in such forms as electromagnetic radiation or acoustic energy there through; and, a window (40) operatively positioned with respect to the first sheath (32) so as to enable viewing of an area substantially adjacent the second sheath (34) upon insertion of the medical device (50) into the apparatus (10).
Patent CA-2508699-A1 (CA)
Inventor: KELLY HENRY ANDERSON
IPC: C07D409/12
Filed: 2003-12-04
Abstract: L'invention concerne des (E)-2-(5-chlorothiène-2-yle)-N-{(3S)-1[(1S)-1-méthyle-2-morpholine-4-yle-2-oxoéthyle]-2-oxopyrrolidine-3-yle}éthène-sulfonamides sous forme sensiblement cristalline, des formulations pharmaceutiques desdits composés, des procédés de préparation correspondants et leur utilisation dans le domaine médical, notamment pour améliorer un état clinique pour lequel un inhibiteur du facteur Xa est indiqué.
Patent CA-2512952-A1 (CA)
Title: Depigmentation agents
Inventor: GATTRELL WILLIAM THOMAS
IPC: A61Q19/02
Filed: 2004-01-30
Abstract: The present invention is directed to 4-cyclopentyl resorcinol monohydrate, its Form I polymorph, formulations containing at least one of these compounds, and their use to lighten skin.
Patent CA-2513024-A1 (CA)
Title: Vibrio cholerae lps detoxified derivatives and immunogenic compositions containing them
Inventor: MULARD LAURENCE
IPC: A61P31/04
Filed: 2005-07-22
Abstract: The presence of a free amino group on the D-glucosamine residue of the detoxified lipopolysaccharide (LPS) of Vibrio cholerae is exploited for the site-specific derivatization of this polysaccharide. The invention allows the preparation of V. cholerae LPS derivatives useful for the immuno-detection. The invention also provides a convenient way to prepare detoxified LPS of V. cholerae (and especially V. cholerae O1, serotype Inaba)-immunogenic carrier conjugates. Thanks to the single modification introduced following the adopted strategy, all derivatives of the detoxified LPS can be fully analyzed in term of purity and identity. This leads to an improved characterization of the conjugates and a better control of their preparation processes.
Patent CA-2513212-A1 (CA)
Title: Improved configuration and process for shift conversion
Inventor: RAO ASHOK
IPC: C10K3/04
Filed: 2004-01-13
Abstract: Overall steam demand for hydrogen production in shift reactor is lowered by splitting the syngas feed stream (101) into first portion (102~) and second portion (102~~). The first portion (102~) is fed to a first shift reactor (110) to form a first product (112). The first product (112) is combined with the second portion (102~~) of the syngas feed prior to entering a second shift reactor (120).
Patent CA-2513904-A1 (CA)
Inventor: QUAN XIAO-JIANG
IPC: A61K38/00
Filed: 2004-01-21
Abstract: The present invention relates to genetic diagnosis and therapy of diseases of the nervous system (NS). More particularly, it relates to methods to induce neural precursor cells (NPCs) and to the identification of a domain that determines the functionality of polypeptides belonging to the atonal family, and its use in therapy for the treatment of deafness, partial hearing loss and vestibular defects due to damage of loss of inner ear hair cells.  Alternatively, the domain may be used in the treatment of cancer.
Patent CA-2513963-A1 (CA)
Title: Terminal-coordinated ringtones
Inventor: MOODY TARYN
IPC: H04M19/02
Filed: 2005-07-28
Abstract: An apparatus and methods are disclosed for enabling multiple telecommunications terminals that are associated with a common user to notify their user of the arrival of an incoming message via a ringtone, where the ringtone is: (i) coordinated across the terminals, and (ii) customized for each terminal based on one or more attributes of the terminal. In particular, in the illustrative embodiments a coordinating terminal that receives a message also directed to another telecommunications terminal sets the values of one or more properties of a ringtone (e.g., tempo, timbre, pitch, rhythm, etc.) based on one or more attributes of the other telecommunications terminal (e.g., terminal type, etc.).
Patent CA-2514813-A1 (CA)
Title: Method and apparatus for measuring polarization mode dispersion
Inventor: CYR NORMAND
IPC: G01J4/04
Filed: 2003-02-06
Abstract: Apparatus for measuring polarization mode dispersion (PMD) of a device, e.g. a waveguide, comprises a broadband light source ( 10,12 ) for passing polarized broadband light through the device ( 14 ), an interferometer ( 20 ) for dividing and recombining light that has passed through the device to form interferograms, a polarization separator ( 30 ) for receiving the light from the interferometer and separating such received light along first and second orthogonal Feb. 25, 2003 Feb. 25, 2003 polarization states, detectors ( 32 <SUB>x</SUB> ,32 <SUB>y</SUB>) for converting the first and second orthogonal polarization states, respectively, into corresponding first and second electrical signals (P<SUB>x</SUB>(tau),P<SUB>y</SUB>(tau)), and a processor ( 36 ) for computing the modulus of the difference and such, respectively, of the first and second electrical signals to produce a cross-correlation envelope (E<SUB>C</SUB>(tau)) and an auto-correlation envelope (E<SUB>c</SUB>(tau)), and determining the polarization mode dispersion according to the expression PMD=where and tau is the delay difference between the paths of the interferometer. <maths id="MATH-US-00001" num="1"> <MATH OVERFLOW="SCROLL"> <MTABLE> <MTR> <MTD> <MROW> <MROW> <MI>PMD</MI> <MO>=</MO> <MSQRT> <MROW> <MFRAC> <MN>3</MN> <MN>2</MN> </MFRAC> <MO>⁢</MO> <MROW> <MO>(</MO> <MROW> <MSUP> <MI>sigma</MI> <MN>2</MN> </MSUP> <MO>-</MO> <MSUBSUP> <MI>sigma</MI> <MN>0</MN> <MN>2</MN> </MSUBSUP> </MROW> <MO>)</MO> </MROW> </MROW> </MSQRT> </MROW> <MO>⁢</MO> <MSTYLE> <MTEXT> </MTEXT> </MSTYLE> <MO>⁢</MO> <MSUP> <MI>sigma</MI> <MN>2</MN> </MSUP> <MO>=</MO> <MROW> <MROW> <MFRAC> <MROW> <MO>∫</MO> <MROW> <MSUP> <MI>tau</MI> <MN>2</MN> </MSUP> <MO>⁢</MO> <MROW> <MSUBSUP> <MI>E</MI> <MI>C</MI> <MN>2</MN> </MSUBSUP> <MO>⁡</MO> <MROW> <MO>(</MO> <MI>tau</MI> <MO>)</MO> </MROW> </MROW> <MO>⁢</MO> <MROW> <MO>ⅆ</MO> <MI>tau</MI> </MROW> </MROW> </MROW> <MROW> <MO>∫</MO> <MROW> <MROW> <MSUBSUP> <MI>E</MI> <MI>C</MI> <MN>2</MN> </MSUBSUP> <MO>⁡</MO> <MROW> <MO>(</MO> <MI>tau</MI> <MO>)</MO> </MROW> </MROW> <MO>⁢</MO> <MROW> <MO>ⅆ</MO> <MI>tau</MI> </MROW> </MROW> </MROW> </MFRAC> <MO>⁢</MO> <MSTYLE> <MTEXT> </MTEXT> </MSTYLE> <MO>⁢</MO> <MI>and</MI> <MO>⁢</MO> <MSTYLE> <MTEXT> </MTEXT> </MSTYLE> <MO>⁢</MO> <MSUBSUP> <MI>sigma</MI> <MN>0</MN> <MN>2</MN> </MSUBSUP> </MROW> <MO>=</MO> <MFRAC> <MROW> <MO>∫</MO> <MROW> <MSUP> <MI>tau</MI> <MN>2</MN> </MSUP> <MO>⁢</MO> <MROW> <MSUBSUP> <MI>E</MI> <MI>A</MI> <MN>2</MN> </MSUBSUP> <MO>⁡</MO> <MROW> <MO>(</MO> <MI>tau</MI> <MO>)</MO> </MROW> </MROW> <MO>⁢</MO> <MROW> <MO>ⅆ</MO> <MI>tau</MI> </MROW> </MROW> </MROW> <MROW> <MO>∫</MO> <MROW> <MROW> <MSUBSUP> <MI>E</MI> <MI>A</MI> <MN>2</MN> </MSUBSUP> <MO>⁡</MO> <MROW> <MO>(</MO> <MI>tau</MI> <MO>)</MO> </MROW> </MROW> <MO>⁢</MO> <MROW> <MO>ⅆ</MO> <MI>tau</MI> </MROW> </MROW> </MROW> </MFRAC> </MROW> </MROW> </MTD> <MTD> <MROW> <MO>(</MO> <MI>I</MI> <MO>)</MO> </MROW> </MTD> </MTR> </MTABLE> </MATH> </MATHS>